Cognition Therapeutics (CGTX) Treasury Shares (2023 - 2026)

Cognition Therapeutics (CGTX) has 4 years of Treasury Shares data on file, last reported at $4.1 million in Q1 2026.

• Quarterly Treasury Shares rose 14.12% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 14.12% YoY) and the FY2025 annual result came in at $2.4 million, up 107.48% from the prior year.
• Treasury Shares grew to $4.1 million in Q1 2026 per CGTX's latest filing, from $2.4 million in the prior quarter.
• Across five years, Treasury Shares topped out at $4.1 million in Q1 2026 and bottomed at $375870.0 in Q1 2023.
• The 4-year median for Treasury Shares is $1.2 million (2024), against an average of $1.8 million.
• The widest annual swing landed in 2024, when Treasury Shares jumped 218.4%; it then grew 14.12% in 2026.
• Tracing CGTX's Treasury Shares over 4 years: stood at $522155.0 in 2023, then surged by 124.64% to $1.2 million in 2024, then jumped by 107.48% to $2.4 million in 2025, then jumped by 67.61% to $4.1 million in 2026.
• Per Business Quant, the three latest CGTX Treasury Shares figures stand at $4.1 million (Q1 2026), $2.4 million (Q4 2025), and $2.7 million (Q3 2025).

Peer Comparison